✦ LIBER ✦

Small-for-size liver transplanted into larger recipient: A model of hepatic regeneration

✍ Scribed by Antonio Francavilla; Qihua Zeng; Lorenzo Polimeno; Brian I. Carr; Dantong Sun; Kendrick A. Porter; David H. van Thiel; Thomas E. Starzl

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 717 KB
Volume: 19
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840190131

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Porcine partial liver transplantation: A

Porcine partial liver transplantation: A novel model of the “small-for-size” liver graft

✍ Dympna M. Kelly; A. Jake Demetris; John J. Fung; Amadeo Marcos; Yue Zhu; Vladimi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

weight; GWBW, graft weight as a percentage of total body weight; ELV, expected liver volume.

Hepatitis A antibodies in liver transpla

Hepatitis A antibodies in liver transplant recipients: Evidence for loss of immunity posttransplantation

✍ Mehmet Arslan; Russell H. Wiesner; John J. Poterucha; B.John Gross Jr; Nizar N. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

Liver transplant recipients frequently have chronic liver diseases and should be considered for vaccination against hepatitis A virus (HAV). However, persistence of protective antibodies after orthotopic liver transplantation (OLT) has not been shown in this population, which may have implications f

Prospective validation of a noninvasive

Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus–infected liver transplant recipients

✍ Salvador Benlloch; Laura Heredia; Claudia Barquero; José-Miguel Rayón; Ramón Pin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

We previously developed a mathematical model, the Hospital Universitario La Fe (HULF) index, as an alternative to protocol liver biopsy (PLB) to estimate significant fibrosis (SF) in patients who underwent liver transplantation (LT) for liver damage caused by chronic HCV infection. In the present st

Reply: Prospective validation of a nonin

Reply: Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus–infected liver transplant recipients

✍ Timothy J. S. Cross; Andrew K. Burroughs; Phillip M. Harrison 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 1 views

Improved outcome of adult recipients wit

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft

✍ Nam-Joon Yi; Kyung-Suk Suh; Hae Won Lee; Woo Young Shin; Juhyun Kim; Won Kim; Yo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

Although adult-to-adult living donor liver transplantation (ALDLT) has shown comparable outcomes to deceased donor liver transplantation, the outcome of patients with a high MELD score (Ͼ25) and a small-for-size graft (SFSGϽ0.8% of graft-torecipient weight ratio) is not known. For 7 years, 167 conse

A 7-gene signature of the recipient pred

A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection

✍ Nicole T. do O; Dennis Eurich; Petra Schmitz; Maximilian Schmeding; Christoph He 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 802 KB

Fibrosis recurrence after liver transplantation (LT) for hepatitis C virus (HCV) is a universal event and strongly determines a patient's prognosis. The recipient risk factors for fibrosis recurrence are still poorly defined. Here we assess a genetic risk score as a predictor of fibrosis after LT. T